Description

DSIP — 5 mg

Investigational Peptide for Sleep & Wellness Support

DSIP (Delta Sleep-Inducing Peptide) is an investigational peptide that has been studied for its potential relationship with sleep regulation and stress-response pathways. Early research has explored its possible effects on sleep patterns, neuroendocrine signaling, and the body’s response to stress.

DSIP is sometimes discussed in wellness settings for potential support of restful sleep and relaxation. However, clinical evidence in humans remains limited, and DSIP is not an FDA-approved medication for insomnia, sleep disorders, or general wellness.

If considered as part of a sleep or wellness program, its potential benefits, limitations, and risks should be reviewed with a qualified healthcare professional following an individualized clinical evaluation.

Treatment eligibility is determined individually following an appropriate clinical evaluation.